Profile data is unavailable for this security.
About the company
Jupiter Bioscience Limited is an India-based company. The Company is engaged in the business of manufacturing peptide group products, drug intermediates, specialty, and fine chemicals. The generic names of certain products of the Company are 4-Chloro Resorcinol, ECCP Alanine, Dibenzyl Glycyl Salicylamide, and 3 4 5 Trimethoxy Benzaldehyde. Its subsidiaries include Sven Genetech Limited, Jupiter Bioscience Inc., and Jupiter Bioscience (HK) Ltd.
- Revenue in INR (TTM)--
- Net income in INR--
- Incorporated1985
- Employees--
- LocationJupiter Bioscience Ltd24, Kolhar I D A,BIDAR 585401IndiaIND
- Phone+91 4 044778080
- Fax+91 4 027702515
- Websitehttp://www.jupiterbioscience.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Saroja Pharma Industries India Ltd | -100.00bn | -100.00bn | 217.11m | 16.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -18.97 | -- | -17.19 | -- | -- | -- |
| Vilin Bio Med Ltd | -100.00bn | -100.00bn | 329.92m | -- | -- | 3.80 | -- | -- | -- | -- | -- | 6.22 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.9741 | -- | 0.4159 | -- | -4.27 | -- | -72.38 | -- | -- | -- |
| Jupiter Bioscience Ltd | -100.00bn | -100.00bn | 372.38m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 5.42 | -- | 5.61 | -- | 61.37 | -- | 17.32 | -- | -- | -- | 10.48 | 42.43 | 29.30 | 20.92 | 22.82 | 55.40 | -16.74 |
| Vivimed Labs Ltd | 1.47bn | -3.17bn | 410.42m | 607.00 | -- | -- | -- | 0.2783 | -38.77 | -38.77 | 17.88 | -- | -- | -- | -- | 2,429,737.00 | -- | -5.92 | -- | -8.97 | -62.46 | 33.74 | -214.73 | -14.20 | -- | -6.31 | -- | -- | -21.15 | -30.83 | -385.64 | -- | -- | -- |
| Vineet Laboratories Ltd | 1.37bn | 1.46m | 528.62m | -- | 327.77 | 1.62 | 19.83 | 0.386 | 0.1749 | 0.1749 | 148.76 | 35.35 | -- | -- | -- | -- | -- | -- | -- | -- | 25.44 | -- | 0.107 | -- | 0.4833 | 0.7313 | 0.565 | -- | -29.06 | -- | -18.00 | -- | -- | -- |
Data as of Jan 11 2013. Currency figures normalised to Jupiter Bioscience Ltd's reporting currency: Indian Rupee INR
